about
Anticancer activity of novel amino acid derivative of palladium complex with phendione ligand against of human colon cancer cell line.The mitochondrial apoptotic pathway is induced by Cu(II) antineoplastic compounds (Casiopeínas®) in SK-N-SH neuroblastoma cells after short exposure times.The effect of potential supramolecular-bond promoters on the DNA-interacting abilities of copper-terpyridine compounds.Synthesis, DNA binding, hemolysis assays and anticancer studies of copper(II), nickel(II) and iron(III) complexes of a pyrazoline-based ligand.Potential cytotoxic and amoebicide activity of first row transition metal compounds with 2,9-bis-(2',5'-diazahexanyl)-1,1-phenanthroline (L1).Interaction of anticancer Ru(III) complexes with single stranded and duplex DNA model systems.Intercalation processes of copper complexes in DNA.Pharmacokinetics and hematotoxicity of a novel copper-based anticancer agent: casiopeina III-Ea, after a single intravenous dose in rats.Synthesis, structure and cytotoxicity of cyclic (alkyl)(amino) carbene and acyclic carbene complexes of group 11 metals.HSA-based multi-target combination therapy: regulating drugs' release from HSA and overcoming single drug resistance in a breast cancer model.Synthesis and crystal structures of novel copper(II) complexes with glycine and substituted phenanthrolines: reactivity towards DNA/BSA and in vitro cytotoxic and antimicrobial evaluation.Copper oxide nanoparticles and copper sulphate act as antigenotoxic agents in drosophila melanogaster.Di-copper metallodrugs promote NCI-60 chemotherapy via singlet oxygen and superoxide production with tandem TA/TA and AT/AT oligonucleotide discrimination.Genotoxicity of Casiopeina III-Ea in mouse bone marrow cells.Analysis of the DNA interaction of copper compounds belonging to the Casiopeínas® antitumoral series.In vitro DNA damage by Casiopeina II-gly in human blood cells.Ex Vivo Cardiotoxicity of Antineoplastic Casiopeinas Is Mediated through Energetic Dysfunction and Triggered Mitochondrial-Dependent Apoptosis.In vitro and in vivo studies into the biological activities of 1,10-phenanthroline, 1,10-phenanthroline-5,6-dione and its copper(ii) and silver(i) complexesVIVO and CuII complexation by ligands based on pyridine nitrogen donors
P2860
Q38639555-D6474ED3-98F7-47A9-AC00-7A42E170A3EDQ38725601-3D58FFAA-9D67-4610-93B4-7A7EDECA4A0DQ38842569-4C31644E-3EA0-4256-BE61-D0D2DEF2D37EQ39202622-09FFD3D1-1415-4B2F-B5F4-747A164C67E4Q39327176-3B217A12-8339-4499-911D-51B0ABF2FF83Q40759010-5CA5BC34-8B7E-4AF5-B81D-1F3B8654B95FQ42210092-B2EC20C8-A931-45FC-BE44-86AC27711E43Q44103442-A2996E91-4203-4451-A983-CA55BDBBD37BQ46266202-3DDC6833-9E95-4A94-A10F-10DB16809AF5Q49928163-6C5CDC22-7EBE-4FFB-A6E8-73212D303D3BQ50550654-E00D4624-96BB-4635-A9E5-1F5F2337FAABQ50956562-99FD30BF-3CD5-4FA8-B124-D04BB95C3915Q52374153-D44EE975-7048-4DBC-8ECA-50786D2557E1Q52860466-A54AAF3D-C7CC-482B-8062-832984E0352EQ53027836-36B0399E-0B16-442C-9B17-D9FA745910D7Q53080070-05CBF6D7-91CB-4A0A-B3E8-E41603A259BCQ53820259-BD5C5B83-B651-44B5-A9C5-FB9FB98B6219Q58838263-01A52FD2-6581-4FDD-975F-F2274833BD08Q59082951-909D4CE6-1164-47F9-A4AE-A3BBB5C4B3C9
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on January 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Copper compounds in cancer chemotherapy.
@en
Copper compounds in cancer chemotherapy.
@nl
type
label
Copper compounds in cancer chemotherapy.
@en
Copper compounds in cancer chemotherapy.
@nl
prefLabel
Copper compounds in cancer chemotherapy.
@en
Copper compounds in cancer chemotherapy.
@nl
P1476
Copper compounds in cancer chemotherapy.
@en
P2093
Bravo-Gómez ME
Ruiz-Azuara L
P304
P356
10.2174/092986710793213751
P577
2010-01-01T00:00:00Z